Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Recurrence 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid 2Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cytarabine 72Etoposide 29Daunorubicin 25Filgrastim 24Idarubicin 22Mitoxantrone 21Busulfan 21Peripheral Blood Stem Cell Transplantation 20Cyclophosphamide 20fludarabine phosphate 18Gemtuzumab 13Antilymphocyte Serum 12tipifarnib 11Radiotherapy 11Gene Expression Profiling 10Flow Cytometry 10Cyclosporine 10Clofarabine 10sargramostim 9Methotrexate 9Azacitidine 8aldesleukin 6Vorinostat 6Topotecan 6Tacrolimus 6valspodar 5alvocidib 5Whole-Body Irradiation 5Granulocyte Colony-Stimulating Factor 5Cord Blood Stem Cell Transplantation 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Megakaryoblastic, Acute × zosuquidar trihydrochloride × Clear all
NCT00046930 2023-07-05

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

Eastern Cooperative Oncology Group

Phase 3 Completed
449 enrolled 9 charts
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡